Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Iovance Biotherapeutics Inc Share Price

IOVA

NMQ

$2.815

-$0.04

(-1.4%)

Industry: Biotechnology Sector: Health Care

Iovance Biotherapeutics Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Iovance Biotherapeutics Inc Share Price Chart

Iovance Biotherapeutics Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$1.13B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

2.13M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.78

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$1.64 L

$6.09 H

$2.815

About Iovance Biotherapeutics Inc, Common Stock

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic melanoma and metastatic renal cell carcinoma. It develops lifileucel for treatment of melanoma, cervical cancer, non-small cell lung cancer (NSCLC), endometrial cancer, and head and neck squamous cell carcinoma; IOV-2001 to treat chronic lymphocytic leukemia and small lymphocytic lymphoma; IOV-4001 for the treatment of melanoma and NSCLC; and IOV-3001, an antibody cytokine engrafted protein for use in the TIL therapy treatment regimen. The company has collaborations and licensing agreements with WuXi Advanced Therapies, Inc.; National Institutes of Health; the National Cancer Institute; H. Lee Moffitt Cancer Center; The University of Texas M.D. Anderson Cancer Center; Cellectis S.A.; Novartis Pharma AG; and Boehringer Ingelheim Biopharmaceuticals GmbH. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California. more

Industry: BiotechnologySector: Health Care

Iovance Biotherapeutics Inc Stock Returns

Time Frame	IOVA	Sector	S&P500
1-Week Return	13.1%	0.81%	0.49%
1-Month Return	16.8%	1.2%	1.02%
3-Month Return	26.11%	3.24%	3.34%
6-Month Return	9.62%	14.99%	7.04%
1-Year Return	-49.56%	7.42%	11.68%
3-Year Return	-59.46%	20.71%	71.63%
5-Year Return	-93.96%	37.45%	75.56%
10-Year Return	-45.09%	138.53%	257.55%

Time Frame	IOVA	Sector	S&P500
1-Week Return	61,232.83%	52.30%	29.03%
1-Month Return	561.54%	15.62%	13.14%
3-Month Return	156.21%	13.80%	14.25%
6-Month Return	20.47%	32.74%	14.79%
1-Year Return	-49.56%	7.42%	11.68%
3-Year Return	-25.99%	6.48%	19.73%
5-Year Return	-42.96%	6.57%	11.91%
10-Year Return	-5.82%	9.08%	13.59%

Iovance Biotherapeutics Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	-	238.00K	1.19M	164.07M	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":0.15,"profit":true},{"date":"2023-12-31","value":0.72,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	8.71M	13.98M	21.14M	10.76M	124.00M	[{"date":"2020-12-31","value":7.03,"profit":true},{"date":"2021-12-31","value":11.27,"profit":true},{"date":"2022-12-31","value":17.05,"profit":true},{"date":"2023-12-31","value":8.67,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	(8.71M)	(13.98M)	(21.14M)	(9.57M)	40.08M	[{"date":"2020-12-31","value":-21.74,"profit":false},{"date":"2021-12-31","value":-34.88,"profit":false},{"date":"2022-12-31","value":-52.74,"profit":false},{"date":"2023-12-31","value":-23.87,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	-	-	(8880.25%)	(804.54%)	24.43%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-36356.41,"profit":false},{"date":"2023-12-31","value":-3293.85,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Operating Expenses	261.94M	342.70M	398.88M	450.99M	435.35M	[{"date":"2020-12-31","value":58.08,"profit":true},{"date":"2021-12-31","value":75.99,"profit":true},{"date":"2022-12-31","value":88.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.53,"profit":true}]
Operating Income	(261.94M)	(342.70M)	(398.88M)	(460.56M)	(395.28M)	[{"date":"2020-12-31","value":-26193700000,"profit":false},{"date":"2021-12-31","value":-34270300000,"profit":false},{"date":"2022-12-31","value":-39887800000,"profit":false},{"date":"2023-12-31","value":-46055900000,"profit":false},{"date":"2024-12-31","value":-39527800000,"profit":false}]
Total Non-Operating Income/Expense	4.71M	902.00K	5.97M	24.68M	40.55M	[{"date":"2020-12-31","value":11.62,"profit":true},{"date":"2021-12-31","value":2.22,"profit":true},{"date":"2022-12-31","value":14.72,"profit":true},{"date":"2023-12-31","value":60.88,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income	(259.58M)	(342.25M)	(395.89M)	(447.52M)	(375.00M)	[{"date":"2020-12-31","value":-25958100000,"profit":false},{"date":"2021-12-31","value":-34225200000,"profit":false},{"date":"2022-12-31","value":-39589300000,"profit":false},{"date":"2023-12-31","value":-44751600000,"profit":false},{"date":"2024-12-31","value":-37500500000,"profit":false}]
Income Taxes	(2.36M)	(14.43M)	(5.97M)	(3.48M)	(2.83M)	[{"date":"2020-12-31","value":-235600000,"profit":false},{"date":"2021-12-31","value":-1443100000,"profit":false},{"date":"2022-12-31","value":-597000000,"profit":false},{"date":"2023-12-31","value":-347900000,"profit":false},{"date":"2024-12-31","value":-282800000,"profit":false}]
Income After Taxes	(257.23M)	(327.82M)	(389.92M)	(444.04M)	(372.18M)	[{"date":"2020-12-31","value":-25722500000,"profit":false},{"date":"2021-12-31","value":-32782100000,"profit":false},{"date":"2022-12-31","value":-38992300000,"profit":false},{"date":"2023-12-31","value":-44403700000,"profit":false},{"date":"2024-12-31","value":-37217700000,"profit":false}]

Income From Continuous Operations	(259.58M)	(342.25M)	(395.89M)	(432.98M)	(372.18M)	[{"date":"2020-12-31","value":-25958100000,"profit":false},{"date":"2021-12-31","value":-34225200000,"profit":false},{"date":"2022-12-31","value":-39589300000,"profit":false},{"date":"2023-12-31","value":-43297700000,"profit":false},{"date":"2024-12-31","value":-37217700000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(259.58M)	(327.82M)	(389.92M)	(444.04M)	(372.18M)	[{"date":"2020-12-31","value":-25958100000,"profit":false},{"date":"2021-12-31","value":-32782100000,"profit":false},{"date":"2022-12-31","value":-38992300000,"profit":false},{"date":"2023-12-31","value":-44403700000,"profit":false},{"date":"2024-12-31","value":-37217700000,"profit":false}]

EPS (Diluted)	(1.89)	(2.22)	(2.48)	(1.88)	(1.30)	[{"date":"2020-12-31","value":-189,"profit":false},{"date":"2021-12-31","value":-222,"profit":false},{"date":"2022-12-31","value":-248,"profit":false},{"date":"2023-12-31","value":-188,"profit":false},{"date":"2024-12-31","value":-130,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	-	-	399.58%	13698.99%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":2.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	-	60.47%	51.18%	(49.11%)	1052.91%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":5.74,"profit":true},{"date":"2022-12-31","value":4.86,"profit":true},{"date":"2023-12-31","value":-4.66,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	-	60.47%	51.18%	(54.74%)	(518.93%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.64,"profit":true},{"date":"2023-12-31","value":-90.52,"profit":false},{"date":"2024-12-31","value":-858.19,"profit":false}]
Gross Margin	-	-	-	(90.94%)	(103.04%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

Operating Expenses	-	30.83%	16.39%	13.07%	(3.47%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":53.16,"profit":true},{"date":"2023-12-31","value":42.37,"profit":true},{"date":"2024-12-31","value":-11.25,"profit":false}]
Operating Income	-	30.83%	16.39%	15.46%	(14.17%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":53.16,"profit":true},{"date":"2023-12-31","value":50.15,"profit":true},{"date":"2024-12-31","value":-45.97,"profit":false}]
Total Non-Operating Income/Expense	-	(80.86%)	561.86%	313.48%	64.25%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-14.39,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":55.79,"profit":true},{"date":"2024-12-31","value":11.44,"profit":true}]
Pre-Tax Income	-	31.85%	15.67%	13.04%	(16.20%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":49.21,"profit":true},{"date":"2023-12-31","value":40.94,"profit":true},{"date":"2024-12-31","value":-50.88,"profit":false}]
Income Taxes	-	512.52%	(58.63%)	(41.73%)	(18.71%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-11.44,"profit":false},{"date":"2023-12-31","value":-8.14,"profit":false},{"date":"2024-12-31","value":-3.65,"profit":false}]
Income After Taxes	-	27.45%	18.94%	13.88%	(16.18%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":69.02,"profit":true},{"date":"2023-12-31","value":50.57,"profit":true},{"date":"2024-12-31","value":-58.97,"profit":false}]

Income From Continuous Operations	-	31.85%	15.67%	9.37%	(14.04%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":49.21,"profit":true},{"date":"2023-12-31","value":29.41,"profit":true},{"date":"2024-12-31","value":-44.09,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	26.29%	18.94%	13.88%	(16.18%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":72.06,"profit":true},{"date":"2023-12-31","value":52.79,"profit":true},{"date":"2024-12-31","value":-61.56,"profit":false}]

EPS (Diluted)	-	17.46%	11.71%	(24.19%)	(30.85%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":67.08,"profit":true},{"date":"2023-12-31","value":-138.56,"profit":false},{"date":"2024-12-31","value":-176.69,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	58.55M	73.69M	49.32M	59.95M	67.45M	[{"date":"2024-09-30","value":79.46,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":66.93,"profit":true},{"date":"2025-06-30","value":81.35,"profit":true},{"date":"2025-09-30","value":91.53,"profit":true}]
Cost of Revenue	39.82M	45.54M	49.74M	56.66M	1.41M	[{"date":"2024-09-30","value":70.28,"profit":true},{"date":"2024-12-31","value":80.37,"profit":true},{"date":"2025-03-31","value":87.78,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":2.48,"profit":true}]
Gross Profit	18.73M	28.15M	(417.00K)	3.29M	66.05M	[{"date":"2024-09-30","value":28.36,"profit":true},{"date":"2024-12-31","value":42.62,"profit":true},{"date":"2025-03-31","value":-0.63,"profit":false},{"date":"2025-06-30","value":4.98,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	31.99%	38.20%	(0.85%)	5.48%	97.91%	[{"date":"2024-09-30","value":32.67,"profit":true},{"date":"2024-12-31","value":39.01,"profit":true},{"date":"2025-03-31","value":-0.86,"profit":false},{"date":"2025-06-30","value":5.6,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Operating Expenses	107.80M	114.73M	120.80M	117.06M	160.95M	[{"date":"2024-09-30","value":66.98,"profit":true},{"date":"2024-12-31","value":71.28,"profit":true},{"date":"2025-03-31","value":75.06,"profit":true},{"date":"2025-06-30","value":72.73,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Operating Income	(89.07M)	(86.58M)	(121.22M)	(113.77M)	(94.90M)	[{"date":"2024-09-30","value":-8906600000,"profit":false},{"date":"2024-12-31","value":-8657600000,"profit":false},{"date":"2025-03-31","value":-12122100000,"profit":false},{"date":"2025-06-30","value":-11377400000,"profit":false},{"date":"2025-09-30","value":-9490100000,"profit":false}]
Total Non-Operating Income/Expense	8.01M	19.15M	6.44M	8.21M	2.49M	[{"date":"2024-09-30","value":41.83,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":33.63,"profit":true},{"date":"2025-06-30","value":42.86,"profit":true},{"date":"2025-09-30","value":12.98,"profit":true}]
Pre-Tax Income	(85.06M)	(77.00M)	(118.00M)	(109.67M)	(93.66M)	[{"date":"2024-09-30","value":-8506100000,"profit":false},{"date":"2024-12-31","value":-7700100000,"profit":false},{"date":"2025-03-31","value":-11800100000,"profit":false},{"date":"2025-06-30","value":-10967000000,"profit":false},{"date":"2025-09-30","value":-9365800000,"profit":false}]
Income Taxes	(1.52M)	1.56M	(1.84M)	1.99M	(2.40M)	[{"date":"2024-09-30","value":-76.46,"profit":false},{"date":"2024-12-31","value":78.37,"profit":true},{"date":"2025-03-31","value":-92.45,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-120.98,"profit":false}]
Income After Taxes	(83.54M)	(78.56M)	(116.16M)	(111.66M)	(91.25M)	[{"date":"2024-09-30","value":-8354100000,"profit":false},{"date":"2024-12-31","value":-7855900000,"profit":false},{"date":"2025-03-31","value":-11616300000,"profit":false},{"date":"2025-06-30","value":-11165800000,"profit":false},{"date":"2025-09-30","value":-9125300000,"profit":false}]

Income From Continuous Operations	(83.54M)	(78.56M)	(116.16M)	(111.66M)	(91.25M)	[{"date":"2024-09-30","value":-8354100000,"profit":false},{"date":"2024-12-31","value":-7855900000,"profit":false},{"date":"2025-03-31","value":-11616300000,"profit":false},{"date":"2025-06-30","value":-11165800000,"profit":false},{"date":"2025-09-30","value":-9125300000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(83.54M)	(78.56M)	(116.16M)	(111.66M)	(91.25M)	[{"date":"2024-09-30","value":-8354100000,"profit":false},{"date":"2024-12-31","value":-7855900000,"profit":false},{"date":"2025-03-31","value":-11616300000,"profit":false},{"date":"2025-06-30","value":-11165800000,"profit":false},{"date":"2025-09-30","value":-9125300000,"profit":false}]

EPS (Diluted)	(0.28)	(0.26)	(0.36)	(0.33)	(0.25)	[{"date":"2024-09-30","value":-28,"profit":false},{"date":"2024-12-31","value":-26,"profit":false},{"date":"2025-03-31","value":-36,"profit":false},{"date":"2025-06-30","value":-33,"profit":false},{"date":"2025-09-30","value":-25,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	25.86%	(33.07%)	21.55%	12.52%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-127.9,"profit":false},{"date":"2025-06-30","value":83.33,"profit":true},{"date":"2025-09-30","value":48.4,"profit":true}]
Cost of Revenue	-	14.36%	9.22%	13.92%	(97.52%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":64.17,"profit":true},{"date":"2025-06-30","value":96.9,"profit":true},{"date":"2025-09-30","value":-678.91,"profit":false}]
Gross Profit	-	50.29%	(101.48%)	(888.49%)	1908.73%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":2.63,"profit":true},{"date":"2025-03-31","value":-5.32,"profit":false},{"date":"2025-06-30","value":-46.55,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Gross Margin	-	19.41%	(102.21%)	(748.71%)	1685.30%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":1.15,"profit":true},{"date":"2025-03-31","value":-6.06,"profit":false},{"date":"2025-06-30","value":-44.43,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Operating Expenses	-	6.43%	5.30%	(3.10%)	37.49%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":17.15,"profit":true},{"date":"2025-03-31","value":14.13,"profit":true},{"date":"2025-06-30","value":-8.26,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Operating Income	-	(2.80%)	40.02%	(6.14%)	(16.59%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-6.99,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-15.35,"profit":false},{"date":"2025-09-30","value":-41.45,"profit":false}]
Total Non-Operating Income/Expense	-	139.08%	(66.37%)	27.45%	(69.71%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-47.72,"profit":false},{"date":"2025-06-30","value":19.74,"profit":true},{"date":"2025-09-30","value":-50.13,"profit":false}]
Pre-Tax Income	-	(9.48%)	53.25%	(7.06%)	(14.60%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-17.8,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-13.26,"profit":false},{"date":"2025-09-30","value":-27.42,"profit":false}]
Income Taxes	-	(202.50%)	(217.97%)	(208.16%)	(220.98%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Income After Taxes	-	(5.96%)	47.87%	(3.88%)	(18.27%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-12.46,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-8.1,"profit":false},{"date":"2025-09-30","value":-38.18,"profit":false}]

Income From Continuous Operations	-	(5.96%)	47.87%	(3.88%)	(18.27%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-12.46,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-8.1,"profit":false},{"date":"2025-09-30","value":-38.18,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	(5.96%)	47.87%	(3.88%)	(18.27%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-12.46,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-8.1,"profit":false},{"date":"2025-09-30","value":-38.18,"profit":false}]

EPS (Diluted)	-	(7.14%)	38.46%	(8.33%)	(24.24%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-18.57,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-21.67,"profit":false},{"date":"2025-09-30","value":-63.03,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	636.10M	507.96M	479.12M	307.85M	457.02M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":79.85,"profit":true},{"date":"2022-12-31","value":75.32,"profit":true},{"date":"2023-12-31","value":48.4,"profit":true},{"date":"2024-12-31","value":71.85,"profit":true}]
Non-current Assets	132.36M	269.38M	184.87M	472.50M	453.41M	[{"date":"2020-12-31","value":28.01,"profit":true},{"date":"2021-12-31","value":57.01,"profit":true},{"date":"2022-12-31","value":39.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":95.96,"profit":true}]
Total Assets	768.46M	777.33M	663.98M	780.35M	910.43M	[{"date":"2020-12-31","value":84.41,"profit":true},{"date":"2021-12-31","value":85.38,"profit":true},{"date":"2022-12-31","value":72.93,"profit":true},{"date":"2023-12-31","value":85.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	54.87M	89.20M	91.48M	110.31M	122.34M	[{"date":"2020-12-31","value":44.85,"profit":true},{"date":"2021-12-31","value":72.91,"profit":true},{"date":"2022-12-31","value":74.78,"profit":true},{"date":"2023-12-31","value":90.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	57.09M	66.47M	72.86M	85.43M	77.68M	[{"date":"2020-12-31","value":66.82,"profit":true},{"date":"2021-12-31","value":77.81,"profit":true},{"date":"2022-12-31","value":85.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":90.93,"profit":true}]
Total Liabilities	111.96M	155.67M	164.34M	195.74M	200.02M	[{"date":"2020-12-31","value":55.97,"profit":true},{"date":"2021-12-31","value":77.83,"profit":true},{"date":"2022-12-31","value":82.16,"profit":true},{"date":"2023-12-31","value":97.86,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	6.00K	7.00K	8.00K	11.00K	13.00K	[{"date":"2020-12-31","value":46.15,"profit":true},{"date":"2021-12-31","value":53.85,"profit":true},{"date":"2022-12-31","value":61.54,"profit":true},{"date":"2023-12-31","value":84.62,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(830.19M)	(1.17B)	(1.57B)	(2.01B)	(2.38B)	[{"date":"2020-12-31","value":-83019300000,"profit":false},{"date":"2021-12-31","value":-117244500000,"profit":false},{"date":"2022-12-31","value":-156833800000,"profit":false},{"date":"2023-12-31","value":-201237500000,"profit":false},{"date":"2024-12-31","value":-238455200000,"profit":false}]
Other Stockholders' Equity	1.49B	1.79B	2.07B	2.59B	3.10B	[{"date":"2020-12-31","value":48.02,"profit":true},{"date":"2021-12-31","value":57.97,"profit":true},{"date":"2022-12-31","value":66.82,"profit":true},{"date":"2023-12-31","value":83.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	656.50M	621.66M	499.64M	584.61M	710.40M	[{"date":"2020-12-31","value":92.41,"profit":true},{"date":"2021-12-31","value":87.51,"profit":true},{"date":"2022-12-31","value":70.33,"profit":true},{"date":"2023-12-31","value":82.29,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	768.46M	777.33M	663.98M	780.35M	910.43M	[{"date":"2020-12-31","value":84.41,"profit":true},{"date":"2021-12-31","value":85.38,"profit":true},{"date":"2022-12-31","value":72.93,"profit":true},{"date":"2023-12-31","value":85.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	(20.15%)	(5.68%)	(35.75%)	48.46%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-41.57,"profit":false},{"date":"2022-12-31","value":-11.72,"profit":false},{"date":"2023-12-31","value":-73.77,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Assets	-	103.52%	(31.37%)	155.59%	(4.04%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":66.53,"profit":true},{"date":"2022-12-31","value":-20.16,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-2.6,"profit":false}]
Total Assets	-	1.15%	(14.58%)	17.53%	16.67%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":6.59,"profit":true},{"date":"2022-12-31","value":-83.2,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":95.11,"profit":true}]

Total Liabilities
Current Liabilities	-	62.56%	2.56%	20.57%	10.91%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":4.09,"profit":true},{"date":"2023-12-31","value":32.88,"profit":true},{"date":"2024-12-31","value":17.44,"profit":true}]
Non-current Liabilities	-	16.44%	9.61%	17.26%	(9.07%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":95.26,"profit":true},{"date":"2022-12-31","value":55.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-52.58,"profit":false}]
Total Liabilities	-	39.04%	5.57%	19.10%	2.19%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":14.26,"profit":true},{"date":"2023-12-31","value":48.93,"profit":true},{"date":"2024-12-31","value":5.6,"profit":true}]

Total Shareholders' equity
Common Stock	-	16.67%	14.29%	37.50%	18.18%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":44.44,"profit":true},{"date":"2022-12-31","value":38.1,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":48.48,"profit":true}]
Retained Earnings	-	41.23%	33.77%	28.31%	18.49%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.91,"profit":true},{"date":"2023-12-31","value":68.68,"profit":true},{"date":"2024-12-31","value":44.86,"profit":true}]
Other Stockholders' Equity	-	20.72%	15.28%	25.40%	19.33%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":81.56,"profit":true},{"date":"2022-12-31","value":60.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":76.09,"profit":true}]
Total Shareholders' equity	-	(5.31%)	(19.63%)	17.01%	21.52%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-24.66,"profit":false},{"date":"2022-12-31","value":-91.22,"profit":false},{"date":"2023-12-31","value":79.04,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	1.15%	(14.58%)	17.53%	16.67%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":6.59,"profit":true},{"date":"2022-12-31","value":-83.2,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":95.11,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	498.58M	457.02M	512.65M	422.50M	429.09M	[{"date":"2024-09-30","value":97.26,"profit":true},{"date":"2024-12-31","value":89.15,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":82.42,"profit":true},{"date":"2025-09-30","value":83.7,"profit":true}]
Non-current Assets	492.54M	453.41M	454.09M	484.94M	475.86M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":92.06,"profit":true},{"date":"2025-03-31","value":92.19,"profit":true},{"date":"2025-06-30","value":98.46,"profit":true},{"date":"2025-09-30","value":96.61,"profit":true}]
Total Assets	991.12M	910.43M	966.74M	907.44M	904.95M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":91.86,"profit":true},{"date":"2025-03-31","value":97.54,"profit":true},{"date":"2025-06-30","value":91.56,"profit":true},{"date":"2025-09-30","value":91.31,"profit":true}]

Total Liabilities
Current Liabilities	118.06M	122.34M	122.69M	129.16M	125.78M	[{"date":"2024-09-30","value":91.41,"profit":true},{"date":"2024-12-31","value":94.72,"profit":true},{"date":"2025-03-31","value":95,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":97.39,"profit":true}]
Non-current Liabilities	99.60M	77.68M	76.18M	79.79M	76.88M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":77.99,"profit":true},{"date":"2025-03-31","value":76.48,"profit":true},{"date":"2025-06-30","value":80.11,"profit":true},{"date":"2025-09-30","value":77.18,"profit":true}]
Total Liabilities	217.66M	200.02M	198.88M	208.95M	202.66M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":91.9,"profit":true},{"date":"2025-03-31","value":91.37,"profit":true},{"date":"2025-06-30","value":96,"profit":true},{"date":"2025-09-30","value":93.11,"profit":true}]

Total Shareholders' equity
Common Stock	13.00K	13.00K	14.00K	14.00K	16.00K	[{"date":"2024-09-30","value":81.25,"profit":true},{"date":"2024-12-31","value":81.25,"profit":true},{"date":"2025-03-31","value":87.5,"profit":true},{"date":"2025-06-30","value":87.5,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(2.31B)	(2.38B)	(2.50B)	(2.61B)	(2.70B)	[{"date":"2024-09-30","value":-230599300000,"profit":false},{"date":"2024-12-31","value":-238455200000,"profit":false},{"date":"2025-03-31","value":-250071500000,"profit":false},{"date":"2025-06-30","value":-261237300000,"profit":false},{"date":"2025-09-30","value":-270362600000,"profit":false}]
Other Stockholders' Equity	3.06B	3.10B	3.26B	3.29B	3.39B	[{"date":"2024-09-30","value":90.37,"profit":true},{"date":"2024-12-31","value":91.33,"profit":true},{"date":"2025-03-31","value":96.24,"profit":true},{"date":"2025-06-30","value":97.06,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	773.46M	710.40M	767.87M	698.49M	702.29M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":91.85,"profit":true},{"date":"2025-03-31","value":99.28,"profit":true},{"date":"2025-06-30","value":90.31,"profit":true},{"date":"2025-09-30","value":90.8,"profit":true}]

Total Liabilities & Shareholders Equity	991.12M	910.43M	966.74M	907.44M	904.95M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":91.86,"profit":true},{"date":"2025-03-31","value":97.54,"profit":true},{"date":"2025-06-30","value":91.56,"profit":true},{"date":"2025-09-30","value":91.31,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(8.34%)	12.17%	(17.58%)	1.56%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-68.48,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-144.46,"profit":false},{"date":"2025-09-30","value":12.82,"profit":true}]
Non-current Assets	-	(7.94%)	0.15%	6.79%	(1.87%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-116.95,"profit":false},{"date":"2025-03-31","value":2.22,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-27.56,"profit":false}]
Total Assets	-	(8.14%)	6.19%	(6.13%)	(0.27%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-131.62,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-99.17,"profit":false},{"date":"2025-09-30","value":-4.43,"profit":false}]

Total Liabilities
Current Liabilities	-	3.63%	0.29%	5.27%	(2.61%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":68.92,"profit":true},{"date":"2025-03-31","value":5.46,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-49.54,"profit":false}]
Non-current Liabilities	-	(22.01%)	(1.93%)	4.74%	(3.66%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-464.25,"profit":false},{"date":"2025-03-31","value":-40.67,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-77.13,"profit":false}]
Total Liabilities	-	(8.10%)	(0.57%)	5.07%	(3.01%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-159.98,"profit":false},{"date":"2025-03-31","value":-11.31,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-59.41,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	7.69%	-	14.29%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":53.85,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	-	3.41%	4.87%	4.47%	3.49%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":69.93,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":91.66,"profit":true},{"date":"2025-09-30","value":71.71,"profit":true}]
Other Stockholders' Equity	-	1.07%	5.37%	0.85%	3.03%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":19.93,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":15.82,"profit":true},{"date":"2025-09-30","value":56.48,"profit":true}]
Total Shareholders' equity	-	(8.15%)	8.09%	(9.04%)	0.54%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-100.78,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-111.7,"profit":false},{"date":"2025-09-30","value":6.72,"profit":true}]

Total Liabilities & Shareholders Equity	-	(8.14%)	6.19%	(6.13%)	(0.27%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-131.62,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-99.17,"profit":false},{"date":"2025-09-30","value":-4.43,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(205.13M)	(227.94M)	(292.76M)	(361.82M)	(352.98M)	[{"date":"2020-12-31","value":-20513400000,"profit":false},{"date":"2021-12-31","value":-22794100000,"profit":false},{"date":"2022-12-31","value":-29275700000,"profit":false},{"date":"2023-12-31","value":-36182000000,"profit":false},{"date":"2024-12-31","value":-35297700000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(317.85M)	132.00K	256.45M	(155.24M)	(96.41M)	[{"date":"2020-12-31","value":-123.94,"profit":false},{"date":"2021-12-31","value":0.05,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-60.53,"profit":false},{"date":"2024-12-31","value":-37.59,"profit":false}]

Financing Activities
Net Financing Cash Flow	576.42M	239.27M	190.15M	462.96M	390.66M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":41.51,"profit":true},{"date":"2022-12-31","value":32.99,"profit":true},{"date":"2023-12-31","value":80.32,"profit":true},{"date":"2024-12-31","value":67.77,"profit":true}]

Net Change in Cash	53.44M	11.46M	153.85M	(56.84M)	(59.27M)	[{"date":"2020-12-31","value":34.73,"profit":true},{"date":"2021-12-31","value":7.45,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-36.95,"profit":false},{"date":"2024-12-31","value":-38.52,"profit":false}]

Free Cash Flow
Free Cash Flow	(251.93M)	(265.51M)	(313.18M)	(384.11M)	(364.05M)	[{"date":"2020-12-31","value":-25192500000,"profit":false},{"date":"2021-12-31","value":-26551500000,"profit":false},{"date":"2022-12-31","value":-31318200000,"profit":false},{"date":"2023-12-31","value":-38411000000,"profit":false},{"date":"2024-12-31","value":-36404600000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	11.12%	28.44%	23.59%	(2.44%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":39.1,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.96,"profit":true},{"date":"2024-12-31","value":-8.6,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(100.04%)	194184.09%	(160.53%)	(37.90%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-0.05,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-0.08,"profit":false},{"date":"2024-12-31","value":-0.02,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(58.49%)	(20.53%)	143.47%	(15.62%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-40.77,"profit":false},{"date":"2022-12-31","value":-14.31,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-10.88,"profit":false}]

Net Change in Cash	-	(78.56%)	1242.60%	(136.95%)	4.26%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-6.32,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-11.02,"profit":false},{"date":"2024-12-31","value":0.34,"profit":true}]

Free Cash Flow
Free Cash Flow	-	5.39%	17.95%	22.65%	(5.22%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":23.82,"profit":true},{"date":"2022-12-31","value":79.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-23.06,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	(58.97M)	(73.30M)	(103.69M)	(67.45M)	(78.70M)	[{"date":"2024-09-30","value":-5897300000,"profit":false},{"date":"2024-12-31","value":-7329600000,"profit":false},{"date":"2025-03-31","value":-10369400000,"profit":false},{"date":"2025-06-30","value":-6744700000,"profit":false},{"date":"2025-09-30","value":-7870200000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(48.80M)	23.68M	15.87M	13.84M	17.01M	[{"date":"2024-09-30","value":-206.11,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":67.01,"profit":true},{"date":"2025-06-30","value":58.46,"profit":true},{"date":"2025-09-30","value":71.85,"profit":true}]

Financing Activities
Net Financing Cash Flow	41.95M	2.31M	143.31M	13.23M	88.06M	[{"date":"2024-09-30","value":29.27,"profit":true},{"date":"2024-12-31","value":1.61,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":9.23,"profit":true},{"date":"2025-09-30","value":61.44,"profit":true}]

Net Change in Cash	(64.57M)	(48.49M)	56.00M	(39.64M)	25.66M	[{"date":"2024-09-30","value":-115.31,"profit":false},{"date":"2024-12-31","value":-86.6,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-70.78,"profit":false},{"date":"2025-09-30","value":45.83,"profit":true}]

Free Cash Flow
Free Cash Flow	(61.26M)	(77.46M)	(109.91M)	(74.91M)	(89.55M)	[{"date":"2024-09-30","value":-6126100000,"profit":false},{"date":"2024-12-31","value":-7746400000,"profit":false},{"date":"2025-03-31","value":-10990500000,"profit":false},{"date":"2025-06-30","value":-7490800000,"profit":false},{"date":"2025-09-30","value":-8954600000,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	24.29%	41.47%	(34.96%)	16.69%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":58.56,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-84.29,"profit":false},{"date":"2025-09-30","value":40.24,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(148.52%)	(32.99%)	(12.76%)	22.90%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-648.51,"profit":false},{"date":"2025-03-31","value":-144.03,"profit":false},{"date":"2025-06-30","value":-55.73,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(94.50%)	6106.80%	(90.77%)	565.58%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-1.55,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-1.49,"profit":false},{"date":"2025-09-30","value":9.26,"profit":true}]

Net Change in Cash	-	(24.90%)	(215.47%)	(170.78%)	(164.75%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	26.45%	41.88%	(31.84%)	19.54%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":63.16,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-76.04,"profit":false},{"date":"2025-09-30","value":46.66,"profit":true}]

Iovance Biotherapeutics Inc Ratios

Iovance Biotherapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	IOVA
Cash Ratio	2.39
Current Ratio	3.41
Quick Ratio	3.00

Iovance Biotherapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	IOVA
ROA (LTM)	-27.12%
ROE (LTM)	-53.89%

Iovance Biotherapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	IOVA
Debt Ratio Lower is generally better. Negative is bad.	0.22
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.78

Iovance Biotherapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	IOVA
Trailing PE	NM
Forward PE	NM
P/S (TTM)	4.31
P/B	1.45
Price/FCF	NM
EV/R	3.08
EV/Ebitda	NM
PEG	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Iovance Biotherapeutics Inc share price today?

Iovance Biotherapeutics Inc (IOVA) share price today is $2.815

Can Indians buy Iovance Biotherapeutics Inc shares?

Yes, Indians can buy shares of Iovance Biotherapeutics Inc (IOVA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IOVA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Iovance Biotherapeutics Inc be purchased?

Yes, you can purchase fractional shares of Iovance Biotherapeutics Inc (IOVA) via the Vested app. You can start investing in Iovance Biotherapeutics Inc (IOVA) with a minimum investment of $1.

How to invest in Iovance Biotherapeutics Inc shares from India?

You can invest in shares of Iovance Biotherapeutics Inc (IOVA) via Vested in three simple steps:

Click on Sign Up or Invest in IOVA stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Iovance Biotherapeutics Inc shares

What is Iovance Biotherapeutics Inc 52-week high and low stock price?

The 52-week high price of Iovance Biotherapeutics Inc (IOVA) is $6.09. The 52-week low price of Iovance Biotherapeutics Inc (IOVA) is $1.64.

What is Iovance Biotherapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Iovance Biotherapeutics Inc (IOVA) is

What is Iovance Biotherapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Iovance Biotherapeutics Inc (IOVA) is 1.45

What is Iovance Biotherapeutics Inc dividend yield?

The dividend yield of Iovance Biotherapeutics Inc (IOVA) is 0.00%

What is the Market Cap of Iovance Biotherapeutics Inc?

The market capitalization of Iovance Biotherapeutics Inc (IOVA) is $1.13B

What is Iovance Biotherapeutics Inc's stock symbol?

The stock symbol (or ticker) of Iovance Biotherapeutics Inc is IOVA

How Can Investors Use Iovance Biotherapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Iovance Biotherapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Iovance Biotherapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Iovance Biotherapeutics Inc shares for Indian investors?

When investing in Iovance Biotherapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Iovance Biotherapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Iovance Biotherapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Iovance Biotherapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Iovance Biotherapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Iovance Biotherapeutics Inc Share Price

Iovance Biotherapeutics Inc Analyst Forecast

Iovance Biotherapeutics Inc Share Price Chart

Iovance Biotherapeutics Inc Key Stock Metrics

About Iovance Biotherapeutics Inc, Common Stock

Iovance Biotherapeutics Inc Stock Returns

Iovance Biotherapeutics Inc Financials

Iovance Biotherapeutics Inc Ratios

Iovance Biotherapeutics Inc Liquidity Ratios

Iovance Biotherapeutics Inc Asset Efficiency Ratios

Iovance Biotherapeutics Inc Liability Ratios

Iovance Biotherapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Iovance Biotherapeutics Inc Share Price

Iovance Biotherapeutics Inc Analyst Forecast

Iovance Biotherapeutics Inc Share Price Chart

Iovance Biotherapeutics Inc Key Stock Metrics

About Iovance Biotherapeutics Inc, Common Stock

Iovance Biotherapeutics Inc Stock Returns

Iovance Biotherapeutics Inc Financials

Iovance Biotherapeutics Inc Ratios

Iovance Biotherapeutics Inc Liquidity Ratios

Iovance Biotherapeutics Inc Asset Efficiency Ratios

Iovance Biotherapeutics Inc Liability Ratios

Iovance Biotherapeutics Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²